Draft Evidence Review
Draft Evidence Review for Breast Cancer: Medication Use to Reduce Risk
This opportunity for public comment expired on February 11, 2019 at 8:00 PM EST
Note: This is a Draft Evidence Review. This draft is distributed solely for the purpose of receiving public input. It has not been disseminated otherwise by the USPSTF. The final Evidence Review will be used to inform the USPSTF Recommendation Statement on this topic.
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Internet Citation: Draft Evidence Review: Breast Cancer: Medication Use to Reduce Risk. U.S. Preventive Services Task Force. January 2019.